ASTRAZENPharmaceuticals
AstraZeneca Pharma India Ltd — Balance Sheet
₹7931.00
-5.75%
AstraZeneca Pharma India Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 2.50 Cr | 2.50 Cr | 2.50 Cr | 2.50 Cr | — |
| Share Issued | 2.50 Cr | 2.50 Cr | 2.50 Cr | 2.50 Cr | — |
| Total Debt | 35.73 Cr | 4.59 Cr | 7.21 Cr | 8.63 Cr | — |
| Tangible Book Value | 769.69 Cr | 709.81 Cr | 588.69 Cr | 511.39 Cr | — |
| Invested Capital | 770.35 Cr | 711.92 Cr | 588.69 Cr | 511.39 Cr | — |
| Working Capital | 639.35 Cr | 575.59 Cr | 451.54 Cr | 373.02 Cr | — |
| Net Tangible Assets | 769.69 Cr | 709.81 Cr | 588.69 Cr | 511.39 Cr | — |
| Capital Lease Obligations | 35.73 Cr | 4.59 Cr | 7.21 Cr | 8.63 Cr | — |
| Common Stock Equity | 770.35 Cr | 711.92 Cr | 588.69 Cr | 511.39 Cr | — |
| Total Capitalization | 770.35 Cr | 711.92 Cr | 588.69 Cr | 511.39 Cr | — |
| Total Equity Gross Minority Interest | 770.35 Cr | 711.92 Cr | 588.69 Cr | 511.39 Cr | — |
| Stockholders Equity | 770.35 Cr | 711.92 Cr | 588.69 Cr | 511.39 Cr | — |
| Other Equity Interest | 765.35 Cr | 3.29 Cr | 2.57 Cr | 1.95 Cr | — |
| Retained Earnings | 632.72 Cr | 578.15 Cr | 455.64 Cr | 378.96 Cr | — |
| Capital Stock | 5.00 Cr | 5.00 Cr | 5.00 Cr | 5.00 Cr | — |
| Common Stock | 5.00 Cr | 5.00 Cr | 5.00 Cr | 5.00 Cr | — |
| Total Liabilities Net Minority Interest | 747.77 Cr | 366.11 Cr | 396.18 Cr | 345.17 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 44.77 Cr | 8.99 Cr | 12.25 Cr | 12.52 Cr | — |
| Other Non Current Liabilities | 9.00 Cr | — | — | — | — |
| Non Current Pension And Other Postretirement Benefit Plans | 6.32 Cr | 6.21 Cr | 8.56 Cr | 7.50 Cr | — |
| Non Current Deferred Revenue | 9.00 Cr | 0.00 | — | — | — |
| Long Term Debt And Capital Lease Obligation | 29.45 Cr | 2.78 Cr | 3.69 Cr | 5.02 Cr | — |
| Long Term Capital Lease Obligation | 29.45 Cr | 2.78 Cr | 3.69 Cr | 5.02 Cr | — |
| Long Term Provisions | 6.32 Cr | 6.21 Cr | 8.56 Cr | — | 6.41 Cr |
| Current Liabilities | 703.00 Cr | 357.12 Cr | 383.93 Cr | 332.65 Cr | — |
| Other Current Liabilities | 97.98 Cr | 21.49 Cr | 33.25 Cr | 11.51 Cr | — |
| Current Debt And Capital Lease Obligation | 6.28 Cr | 1.81 Cr | 3.52 Cr | 3.61 Cr | — |
| Current Capital Lease Obligation | 6.28 Cr | 1.81 Cr | 3.52 Cr | 3.61 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 85.09 Cr | 43.42 Cr | 41.68 Cr | 43.04 Cr | — |
| Current Provisions | 106.53 Cr | 6.61 Cr | 4.64 Cr | 3.85 Cr | — |
| Payables | 466.94 Cr | 234.18 Cr | 260.67 Cr | 239.44 Cr | — |
| Other Payable | 24.71 Cr | 30.74 Cr | 30.23 Cr | 44.02 Cr | — |
| Dividends Payable | 0.56 Cr | 0.27 Cr | 0.14 Cr | 0.04 Cr | — |
| Total Tax Payable | 10.64 Cr | 6.66 Cr | 2.42 Cr | 4.94 Cr | — |
| Accounts Payable | 456.30 Cr | 196.51 Cr | 227.88 Cr | 190.44 Cr | — |
| Total Assets | 1.52K Cr | 1.08K Cr | 984.87 Cr | 856.56 Cr | — |
| Total Non Current Assets | 175.77 Cr | 145.32 Cr | 149.40 Cr | 150.89 Cr | — |
| Other Non Current Assets | 1.57 Cr | 1.75 Cr | 3.09 Cr | 2.99 Cr | — |
| Non Current Prepaid Assets | 66.21 Cr | 56.85 Cr | 57.66 Cr | 57.49 Cr | — |
| Non Current Deferred Taxes Assets | 41.56 Cr | 21.25 Cr | 20.67 Cr | 16.30 Cr | — |
| Investmentin Financial Assets | 8.03 Cr | 2.47 Cr | 3.10 Cr | 2.93 Cr | — |
| Available For Sale Securities | 8.03 Cr | 2.47 Cr | 3.10 Cr | 2.93 Cr | — |
| Goodwill And Other Intangible Assets | 0.66 Cr | 2.11 Cr | 0.00 | — | — |
| Other Intangible Assets | 0.66 Cr | 2.11 Cr | — | — | — |
| Net PPE | 63.58 Cr | 64.84 Cr | 70.19 Cr | 76.69 Cr | — |
| Accumulated Depreciation | -151.79 Cr | -120.70 Cr | -110.64 Cr | -94.72 Cr | — |
| Gross PPE | 63.58 Cr | 185.54 Cr | 180.83 Cr | 171.41 Cr | — |
| Construction In Progress | 0.00 | 0.65 Cr | 1.71 Cr | 2.58 Cr | — |
| Other Properties | 63.58 Cr | 64.57 Cr | 68.86 Cr | 74.50 Cr | — |
| Machinery Furniture Equipment | 115.52 Cr | 120.79 Cr | 115.41 Cr | 108.16 Cr | — |
| Buildings And Improvements | 97.91 Cr | 62.15 Cr | 62.16 Cr | 59.12 Cr | — |
| Land And Improvements | 1.95 Cr | 1.95 Cr | 1.55 Cr | 1.55 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 1.34K Cr | 932.71 Cr | 835.47 Cr | 705.67 Cr | — |
| Other Current Assets | 56.17 Cr | 27.85 Cr | 26.62 Cr | 18.74 Cr | — |
| Restricted Cash | 0.56 Cr | 0.27 Cr | 0.14 Cr | 0.04 Cr | — |
| Prepaid Assets | 57.61 Cr | 29.69 Cr | 26.67 Cr | 18.83 Cr | — |
| Inventory | 548.50 Cr | 227.88 Cr | 190.21 Cr | 140.22 Cr | — |
| Other Inventories | 0.99 Cr | 1.34 Cr | 1.51 Cr | 1.76 Cr | — |
| Finished Goods | 530.21 Cr | 199.31 Cr | 168.60 Cr | 118.35 Cr | — |
| Work In Process | 6.77 Cr | 4.73 Cr | 1.67 Cr | 3.06 Cr | — |
| Raw Materials | 10.53 Cr | 22.50 Cr | 18.43 Cr | 17.05 Cr | — |
| Other Receivables | 0.30 Cr | 16.17 Cr | 10.59 Cr | 12.27 Cr | — |
| Accounts Receivable | 184.88 Cr | 153.13 Cr | 107.52 Cr | 85.89 Cr | — |
| Allowance For Doubtful Accounts Receivable | -22.86 Cr | -22.20 Cr | -16.76 Cr | -15.09 Cr | — |
| Gross Accounts Receivable | 207.74 Cr | 175.33 Cr | 124.28 Cr | 100.98 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 552.50 Cr | 505.57 Cr | 500.34 Cr | 448.42 Cr | — |
| Other Short Term Investments | 16.36 Cr | 18.15 Cr | 10.72 Cr | 12.31 Cr | — |
| Cash And Cash Equivalents | 536.14 Cr | 505.57 Cr | 500.34 Cr | 448.42 Cr | — |
| Cash Financial | 536.14 Cr | 505.57 Cr | 500.34 Cr | 448.42 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on AstraZeneca Pharma India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.